Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|122|19|3051-3058

ISSN： 0008-543x

Source： CANCER, Vol.122, Iss.19, 2016-10, pp. : 3051-3058

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 297-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel risk stratification score for predicting early distant brain failure and salvage whole‐brain radiotherapy after stereotactic radiosurgery for brain metastases

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3836-3843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3244-3245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3243-3244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases: A Retrospective Analysis and Literature Review

By  

Stereotactic and Functional Neurosurgery, Vol. 89, Iss. 6, 2011-10 ,pp. : 329-337

Karger

Access to resources Recommend Favorite